Clinical Trial Update: RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing supraphysiologic testosterone to resensitize prostate cancer and overcome resistance; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-27